These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 26861846)

  • 21. Causative agents and resistance among hospital-acquired and ventilator-associated pneumonia patients at Srinagarind Hospital, northeastern Thailand.
    Reechaipichitkul W; Phondongnok S; Bourpoern J; Chaimanee P
    Southeast Asian J Trop Med Public Health; 2013 May; 44(3):490-502. PubMed ID: 24050082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pneumonia in hospitalized neurologic patients: trends in pathogen distribution and antibiotic susceptibility.
    Lee HS; Moon J; Shin HR; Ahn SJ; Kim TJ; Jun JS; Lee ST; Jung KH; Park KI; Jung KY; Kim M; Lee SK; Chu K
    Antimicrob Resist Infect Control; 2019; 8():25. PubMed ID: 30733859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.
    Maruyama T; Fujisawa T; Okuno M; Toyoshima H; Tsutsui K; Maeda H; Yuda H; Yoshida M; Kobayashi H; Taguchi O; Gabazza EC; Takei Y; Miyashita N; Ihara T; Brito V; Niederman MS
    Clin Infect Dis; 2013 Nov; 57(10):1373-83. PubMed ID: 23999080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia.
    Rello J; Ulldemolins M; Lisboa T; Koulenti D; Mañez R; Martin-Loeches I; De Waele JJ; Putensen C; Guven M; Deja M; Diaz E;
    Eur Respir J; 2011 Jun; 37(6):1332-9. PubMed ID: 20847075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic and pharmacodynamics evaluation of ceftobiprole medocaril for the treatment of hospital-acquired pneumonia.
    Lagacé-Wiens PR; Rubinstein E
    Expert Opin Drug Metab Toxicol; 2013 Jun; 9(6):789-99. PubMed ID: 23590397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ceftobiprole: drug evaluation and place in therapy.
    Giacobbe DR; De Rosa FG; Del Bono V; Grossi PA; Pea F; Petrosillo N; Rossolini GM; Tascini C; Tumbarello M; Viale P; Bassetti M
    Expert Rev Anti Infect Ther; 2019 Sep; 17(9):689-698. PubMed ID: 31553250
    [No Abstract]   [Full Text] [Related]  

  • 27. Healthcare-Associated Pneumonia and Hospital-Acquired Pneumonia: Bacterial Aetiology, Antibiotic Resistance and Treatment Outcomes: A Study From North India.
    Kumar S; Jan RA; Fomda BA; Rasool R; Koul P; Shah S; Khan UH; Qadri SM; Masoodi SR; Mantoo S; Muzamil M
    Lung; 2018 Aug; 196(4):469-479. PubMed ID: 29691645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hospital-acquired pneumonia in critically ill patients: factors associated with episodes due to imipenem-resistant organisms.
    Leroy O; d'Escrivan T; Devos P; Dubreuil L; Kipnis E; Georges H
    Infection; 2005 Jun; 33(3):129-35. PubMed ID: 15940413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ceftobiprole: a review of a broad-spectrum and anti-MRSA cephalosporin.
    Zhanel GG; Lam A; Schweizer F; Thomson K; Walkty A; Rubinstein E; Gin AS; Hoban DJ; Noreddin AM; Karlowsky JA
    Am J Clin Dermatol; 2008; 9(4):245-54. PubMed ID: 18572975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An overview of guidelines for the management of hospital-acquired and ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria.
    Cillóniz C; Dominedò C; Torres A
    Curr Opin Infect Dis; 2019 Dec; 32(6):656-662. PubMed ID: 31567412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for antibiotic resistance in hospital-acquired and ventilator-associated pneumonia.
    Sano M; Shindo Y; Takahashi K; Okumura J; Sakakibara T; Murakami Y; Iguchi M; Yagi T; Matsui S; Hasegawa Y
    J Infect Chemother; 2022 Jun; 28(6):745-752. PubMed ID: 35219577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of Pseudomonas and methicillin-resistant Staphylococcus aureus in hospitalized patients with healthcare-associated pneumonia.
    Metersky ML; Frei CR; Mortensen EM
    Respirology; 2016 Jan; 21(1):157-63. PubMed ID: 26682638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hospital-acquired pneumonia: risk factors, microbiology, and treatment.
    Lynch JP
    Chest; 2001 Feb; 119(2 Suppl):373S-384S. PubMed ID: 11171773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a bedside tool to predict the probability of drug-resistant pathogens among hospitalized adult patients with gram-negative infections.
    Lodise TP; Bonine NG; Ye JM; Folse HJ; Gillard P
    BMC Infect Dis; 2019 Aug; 19(1):718. PubMed ID: 31412809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A phase 3 randomized double-blind comparison of ceftobiprole medocaril versus ceftazidime plus linezolid for the treatment of hospital-acquired pneumonia.
    Awad SS; Rodriguez AH; Chuang YC; Marjanek Z; Pareigis AJ; Reis G; Scheeren TW; Sánchez AS; Zhou X; Saulay M; Engelhardt M
    Clin Infect Dis; 2014 Jul; 59(1):51-61. PubMed ID: 24723282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Telavancin in the treatment of Staphylococcus aureus hospital-acquired and ventilator-associated pneumonia: clinical evidence and experience.
    Liapikou A; Dimakou K; Toumbis M
    Ther Adv Respir Dis; 2016 Aug; 10(4):368-78. PubMed ID: 27340253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial treatment of nosocomial meticillin-resistant Staphylococcus aureus (MRSA) pneumonia: current and future options.
    Welte T; Pletz MW
    Int J Antimicrob Agents; 2010 Nov; 36(5):391-400. PubMed ID: 20724119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early-onset pneumonia after liver transplantation: microbiological findings and therapeutic consequences.
    Weiss E; Dahmani S; Bert F; Janny S; Sommacale D; Dondero F; Francoz C; Belghiti J; Mantz J; Paugam-Burtz C
    Liver Transpl; 2010 Oct; 16(10):1178-85. PubMed ID: 20879016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Keeping it Simple: Impact of a Restrictive Antibiotic Policy for Ventilator-Associated Pneumonia in Trauma Patients on Incidence and Sensitivities of Causative Pathogens.
    Evans CR; Sharpe JP; Swanson JM; Wood GC; Fabian TC; Croce MA; Magnotti LJ
    Surg Infect (Larchmt); 2018 Oct; 19(7):672-678. PubMed ID: 30204541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid.
    Chastre J; Blasi F; Masterton RG; Rello J; Torres A; Welte T
    Clin Microbiol Infect; 2014 Apr; 20 Suppl 4():19-36. PubMed ID: 24580739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.